Abstract
Abstract
Background
Treatment for people with kidney disease is often associated with complicated combinations of medicines. Logistical challenges with traditiona paper-based prescribing means that these patients are particularly susceptible to medication-relation errors and harm.
Aim
To improve the quality of care that people with kidney disease receive across Wales through a Value-Based digital transformation programme.
Setting
Renal units within the National Welsh Renal Clinical Network (WRCN).
Development
A novel Electronic Prescribing & Medicines Administration (EPMA) system, integrated into a patient care record and linked to a patient portal was developed in South West Wales (SWW) region of the WRCN, enabled by the Welsh Government (WG) Efficiency Through Technology Fund. National upscale was enabled through the WG Transformation Fund.
Implementation
EPMA was designed and rolled out initially in SWW region of the WRCN (2018). A dedicated delivery team used the blueprint to finalise and implement a strategy for successful national roll-out eventually across all Wales (completed 2021).
Evaluation
A multi-factorial approach was employed, as both the technology itself and the healthcare system within which it would be introduced, were complex. Continuous cycles of action research involving informal and formal qualitative interviews with service-users ensured that EPMA was accessible and optimally engaging to all target stakeholders (patients and staff). Results confirmed that EPMA was successful in improving the quality of care that people with kidney disease receive across Wales, contributed to Value-Based outcomes, and put people who deliver and access care at the heart of transformation.
Conclusion
Key findings of this study align directly with the national design principles to drive change and transformation, put forward by the WG in their plan for Health and Social Care: prevention and early intervention; safety; independence; voice; seamless care.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference39 articles.
1. Welsh Government. A Healthier Wales: our Plan for Health and Social care. 2018. https://gov.wales/sites/default/files/publications/2019-10/a-healthier-wales-action-plan.pdf. Accessed 07 Jun 2022
2. Welsh Renal Clinical Network. Renal Services in Wales 2016–2020 Delivery Plan. 2016. http://www.wales.nhs.uk/sites3/Documents/773/Renal%20Disease%20Quality%20Delivery%20Plan1.pdf. Accessed 07 Jun 2022
3. NHS. Treatment. In: Chronic kidney disease. 2019. https://www.nhs.uk/conditions/kidney-disease/treatment/. Accessed 07 Jun 2022
4. Chief Medical Officer for Wales’s special edition annual report 2019 to 2020: protecting our health. 2021. https://gov.wales/chief-medical-officer-waless-special-edition-annual-report-2019-2020-protecting-our-health. Accessed 08 Jun 2022
5. Shemilt K, Morecroft CW, Ford JL, et al. Inpatient prescribing systems used in NHS Acute Trusts across England: a managerial perspective. Eur J Hosp Pharm. 2017;24(4):213–7. https://doi.org/10.1136/ejhpharm-2016-000905.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献